TrialOrphanet journal of rare diseases2021

Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).

Takashi Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.